Second-line treatment with docetaxel after failure of a platinum-based chemotherapy in squamous-cell head and neck cancer

Ann Oncol. 2002 Feb;13(2):331-3. doi: 10.1093/annonc/mdf103.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Cisplatin / administration & dosage
  • Docetaxel
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Middle Aged
  • Paclitaxel / analogs & derivatives*
  • Paclitaxel / therapeutic use*
  • Taxoids*
  • Treatment Failure

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel
  • Paclitaxel
  • Cisplatin